Mortality No Different With TAVR for Bicuspid, Tricuspid Stenosis

TUESDAY, June 11, 2019 -- For patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis, there is no significant difference in 30-day or one-year mortality for bicuspid or tricuspid aortic stenosis, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news